Astrotech subsidiary 1st Detect names David Spada global sales director

Astrotech Corporation (NASDAQ: ASTC) announced that its subsidiary 1st Detect Corporation has appointed David Spada as Director of Global Sales. The appointment aims to expand deployment of the company's TRACER 1000 mass spectrometry-based explosives and narcotics trace detector in international security markets.

Spada brings over a decade of trace detection experience from positions at Implant Sciences, Morpho Detection, and Rapiscan Systems. He previously held roles in product management, strategy, and business development, and was responsible for trace detection sales revenue and strategy for the Americas region.

"David brings extensive industry experience and market knowledge to the 1st Detect team, having been at the forefront of new technology adoption throughout his career," said Thomas B. Pickens III, Chairman and CEO of Astrotech and 1st Detect.

The TRACER 1000 uses mass spectrometry technology to provide molecular identification of threat substances in portable systems designed for field deployment. The technology is intended to help security teams reduce false alarms at screening checkpoints.

1st Detect, based in Austin, Texas, develops and manufactures trace detectors for security and detection markets. The company produces TRACER 1000 ETD and TRACER 1000 NTD systems.

Astrotech operates through several wholly owned subsidiaries that serve specialized markets including security screening, agriculture processing, industrial manufacturing, health diagnostics, and environmental testing. The company is headquartered in Austin, Texas.

You May Also Be Interested In

• BigBear.ai adds retired Lt. Gen. Sean Gainey to its board
• FingerMotion names Chris Polimeni as new CFO
• Xos wins U.S. Air Force contract for mobile charging system